# Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.

> **NCT06397846** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 100 (estimated)

## Conditions studied

- Benign Pancreatic Lesion

## Interventions

- **OTHER:** Biological sample

## Key facts

- **NCT ID:** NCT06397846
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-11
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06397846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06397846, "Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06397846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*